General Partner Inc’s Bristol-Myers Squibb BMY Stock Holding History

General Partner Inc’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-101	Closed	-$4.55K	–	172
2025 Q3	$4.55K	Hold	101	–	–	﹤0.01%	165
2025 Q2	$4.67K	Hold	101	–	–	﹤0.01%	168
2025 Q1	$6.16K	Hold	101	–	–	﹤0.01%	167
2024 Q4	$5.71K	Hold	101	–	–	﹤0.01%	165
2024 Q3	$5.23K	Hold	101	–	–	﹤0.01%	153
2024 Q2	$4.2K	Hold	101	–	–	﹤0.01%	159
2024 Q1	$5.48K	Sell	101 -1,500	-94%	-$76.4K	﹤0.01%	163
2023 Q4	$82.1K	Hold	1,601	–	–	0.07%	83
2023 Q3	$92.9K	Hold	1,601	–	–	0.08%	84
2023 Q2	$102K	Hold	1,601	–	–	0.09%	84
2023 Q1	$111K	Buy	1,601 +101	+7%	+$7.12K	0.1%	80
2022 Q4	$108K	Buy	+1,500	New	+$113K	0.1%	78

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

General Partner Inc's BMY Position: Q4 2025 in Review

General Partner Inc sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 101 shares — an estimated $4.55K sold.

General Partner Inc first reported a position in BMY in Q4 2022 and held it in 12 quarters. The position peaked at $111K in Q1 2023. 2,448 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

General Partner Inc reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
General Partner Inc sold 101 Bristol-Myers Squibb shares in Q4 2025, an estimated $4.55K.
General Partner Inc first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 12 quarters.
General Partner Inc's Bristol-Myers Squibb position peaked at $111K in Q1 2023.
2,448 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on General Partner Inc's 13F filing for Q4 2025, filed 6 Jan 2026.